Abstract
Cigarette smoke can increase oxidative DNA damage. The main component in cigarette smoke is nicotine. Nicotine is metabolized to cotinine, which can be regarded as a biomarker for measuring exposure to tobacco smoke. A sensitive, simple, and robust method based on on-line solid-phase extraction liquid chromatography with tandem mass spectrometry (on-line SPE LC-MS/MS) has been developed and validated for the simultaneous determination of 8-OHdG and cotinine. The matrix effects of 8-OHdG and cotinine were measured at 97.1 and 91.7 %, with values for CV at 4.4 and 4.2 %, respectively. The limits of detection of 8-OHdG and cotinine were 10.0 and 5.5 pg mL−1, and the limits of quantification were 40.0 and 20.0 pg mL−1, respectively. The total run time was 12 min. We quantified 8-OHdG and cotinine in the urine of 80 male subjects. The results showed the levels of 8-OHdG and cotinine in smokers were significantly higher than that in non-smokers. Furthermore, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and its glucuronide conjugate (defined as total NNAL) are the nitrosation metabolites of nicotine. In this study, urinary levels of 8-OHdG and cotinine were well correlated with urinary levels of total NNAL. This is also the first study to focus on the future risk of oxidative stress from exposure to cigarette smoke based on the relationship between 8-OHdG levels, cotinine levels, and total NNAL concentrations in the urine of humans.
Similar content being viewed by others
References
Kohen R, Nyska A. Invited review: oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol. 2002;30:620–50.
Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39:44–84.
Fraga CG, Shigenaga MK, Park JW, Degan P, Ames BN. Oxidative damage to DNA during aging: 8-hydroxy-2′-deoxyguanosine in rat organ DNA and urine. Proc Natl Acad Sci U S A. 1990;87:4533–7.
Isobe C, Abe T, Terayama Y. Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2′-deoxyguanosine in the cerebrospinal fluid of patients with living Parkinson’s disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process. Neurosci Lett. 2010;469:159–63.
Watanabe E, Matsuda N, Shiga T, Kajimoto K, Ajiro Y, Kawarai H, et al. Significance of 8-hydroxy-2′-deoxyguanosine levels in patients with idiopathic dilated cardiomyopathy. J Card Fail. 2006;12:527–32.
Bartsch H, Nair J. New DNA-based biomarkers for oxidative stress and cancer chemoprevention studies. Eur J Cancer. 2000;36:1229–34.
Cai Z, Zhao B, Ratka A. Oxidative stress and β-amyloid protein in Alzheimer’s disease. NeuroMolecular Med. 2011;13:223–50.
Rossner Jr P, Svecova V, Milcova A, Lnenickova Z, Solansky I, Sram RJ. Seasonal variability of oxidative stress markers in city bus drivers: part I. Oxidative damage to DNA. Mutat Res/Fundam Mol Mech Mutagen. 2008;642:14–20.
Cooke MS, Evans MD, Dove R, Rozalski R, Gackowski D, Siomek A, et al. DNA repair is responsible for the presence of oxidatively damaged DNA lesions in urine. Mutat Res/Fundam Mol Mech Mutagen. 2005;574:58–66.
Hecht SS. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer. 2003;3:733–44.
Loft S, Vistisen K, Ewertz M, Tjønneland A, Overvad K, Poulsen HE. Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index. Carcinogenesis. 1992;13:2241–7.
Kanaya S, Ikeya M, Yamamoto K, Moriya T, Furuhashi K, Sonoda M, et al. Comparison of an oxidative stress biomarker “urinary 8-hydroxy-2′-deoxyguanosine,” between smokers and non-smokers. BioFactors. 2004;22:255–8.
Kataoka H, Mizuno K, Oda E, Saito A. Determination of the oxidative stress biomarker urinary 8-hydroxy-2′-deoxyguanosine by automated on-line in-tube solid-phase microextraction coupled with liquid chromatography-tandem mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci. 2016;1019:140–6.
Campos C, Guzmán R, López-Fernández E, Casado Á. Urinary biomarkers of oxidative/nitrosative stress in healthy smokers. Inhal Toxicol. 2011;23:148–56.
Lu CY, Ma YC, Chen PC, Wu CC, Chen YC. Oxidative stress of office workers relevant to tobacco smoking and inner air quality. Int J Environ Res Public Health. 2014;11:5586–97.
Benowitz NL, Jacob P. Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clin Pharmacol Ther. 1994;56:483–93.
Shakleya DM, Huestis MA. Simultaneous and sensitive measurement of nicotine, cotinine, trans-3′-hydroxycotinine and norcotinine in human plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr B. 2009;877:3537–42.
Baumann F, Regenthal R, Burgos-Guerrero IL, Hegerl U, Preiss R. Determination of nicotine and cotinine in human serum by means of LC/MS. J Chromatogr B. 2010;878:107–11.
Kardani F, Daneshfar A, Sahrai R. Determination of nicotine, anabasine, and cotinine in urine and saliva samples using single-drop microextraction. J Chromatogr B. 2010;878:2857–62.
Jarvis MJ, Primatesta P, Erens B, Feyerabend C, Bryant A. Measuring nicotine intake in population surveys: comparability of saliva cotinine and plasma cotinine estimates. Nicotine Tob Res. 2003;5:349–55.
Bernert JT, McGuffey JE, Morrison MA, Pirkle JL. Comparison of serum and salivary cotinine measurements by a sensitive high-performance liquid chromatography-tandem mass spectrometry method as an indicator of exposure to tobacco smoke among smokers and nonsmokers. J Anal Toxicol. 2000;24:333–9.
Jarvis MJ, Tunstall-Pedoe H, Feyerabend C, Vesey C, Saloojee Y. Comparison of tests used to distinguish smokers from nonsmokers. Am J Public Health. 1987;77:1435–8.
Shimoi K, Kasai H, Yokota N, Toyokuni S, Kinae N. Comparison between high-performance liquid chromatography and enzyme-linked immunosorbent assay for the determination of 8-hydroxy-2′-deoxyguanosine in human urine. Cancer Epidemiol Biomark Prev. 2002;11:767–70.
Park S, Lee DH, Park JG, Lee YT, Chung J. A sensitive enzyme immunoassay for measuring cotinine in passive smokers. Clin Chim Acta. 2010;411:1238–42.
Tagesson C, Kallberg M, Klintenberg C, Starkhammar H. Determination of urinary 8-hydroxydeoxyguanosine by automated coupled-column high performance liquid chromatography: a powerful technique for assaying in vivo oxidative DNA damage in cancer patients. Eur J Cancer. 1995;31A:934–40.
Samcová E, Marhol P, Opekar F, Langmaier J. Determination of urinary 8-hydroxy-2′-deoxyguanosine in obese patients by HPLC with electrochemical detection. Anal Chim Acta. 2004;516:107–10.
Lin HS, Jenner AM, Ong CN, Huang SH, Whiteman M, Halliwell B. A high-throughput and sensitive methodology for the quantification of urinary 8-hydroxy-2′-deoxyguanosine: measurement with gas chromatography–mass spectrometry after single solid-phase extraction. Biochem J. 2004;380:541–8.
Man CN, Gam LH, Ismail S, Lajis R, Awang R. Simple, rapid and sensitive assay method for simultaneous quantification of urinary nicotine and cotinine using gas chromatography–mass spectrometry. J Chromatogr B. 2006;844:322–7.
Li MJ, Zhang JB, Li WL, Chu QC, Ye JN. Capillary electrophoretic determination of DNA damage markers: content of 8-hydroxy-2′-deoxyguanosine and 8-nitroguanine in urine. J Chromatogr B. 2011;879:3818–22.
Wang CJ, Yang NH, Chang CC, Liou SH, Lee HL. Rapid and simple one-step membrane extraction for the determination of 8-hydroxy-2′-deoxyguanosine in human plasma by a combination of on-line solid phase extraction and LC–MS/MS. J Chromatogr B. 2011;879:3538–43.
Hosozumi C, Toriba A, Chuesaard T, Kameda T, Tang N, Hayakawa K. Analysis of 8-hydroxy-2′-deoxyguanosine in human urine using hydrophilic interaction chromatography with tandem mass spectrometry. J Chromatogr B. 2012;893–894:173–6.
Harri M, Kasai H, Mori T, Tornaeus J, Savela K, Peltonen K. Analysis of 8-hydroxy-2′-deoxyguanosine in urine using high-performance liquid chromatography–electrospray tandem mass spectrometry. J Chromatogr B. 2007;853:242–6.
Li P, Beck WD, Callahan PM, Terry Jr AV, Bartlett MG. Quantitation of cotinine and its metabolites in rat plasma and brain tissue by hydrophilic interaction chromatography tandem mass spectrometry (HILIC–MS/MS). J Chromatogr B. 2012;907:117–25.
Jacob Iii P, Yu L, Duan M, Ramos L, Yturralde O, Benowitz NL. Determination of the nicotine metabolites cotinine and trans-3′-hydroxycotinine in biologic fluids of smokers and non-smokers using liquid chromatography–tandem mass spectrometry: biomarkers for tobacco smoke exposure and for phenotyping cytochrome P450 2A6 activity. J Chromatogr B. 2011;879:267–76.
Sabatini L, Barbieri A, Tosi M, Roda A, Violante FS. A method for routine quantitation of urinary 8-hydroxy-2′-deoxyguanosine based on solid-phase extraction and micro-high-performance liquid chromatography/electrospray ionization tandem mass spectrometry. Rapid Commun Mass Spectrom. 2005;19:147–52.
Song L, Davis W, Abrams SM, Hemiup J, Latif Kazim A, Michael Cummings K, et al. Sensitive and rapid method for the determination of urinary cotinine in non-smokers: an application for studies assessing exposures to second hand smoke (SHS). Anal Chim Acta. 2005;545:200–8.
Scheidweiler KB, Shakleya DM, Huestis MA. Simultaneous quantification of nicotine, cotinine, trans-3′-hydroxycotinine, norcotinine and mecamylamine in human urine by liquid chromatography–tandem mass spectrometry. Clin Chim Acta. 2012;413:978–84.
Meger M, Meger-Kossien I, Schuler-Metz A, Janket D, Scherer G. Simultaneous determination of nicotine and eight nicotine metabolites in urine of smokers using liquid chromatography–tandem mass spectrometry. J Chromatogr B. 2002;778:251–61.
Ceppa F, El Jahiri Y, Mayaudon H, Dupuy O, Burnat P. High-performance liquid chromatographic determination of cotinine in urine in isocratic mode. J Chromatogr B. 2000;746:115–22.
Zhang S, Song X, Zhang W, Luo N, Cai L. Determination of low urinary 8-hydroxy-2′-deoxyguanosine excretion with capillary electrophoresis and molecularly imprinted monolith solid phase microextraction. Sci Total Environ. 2013;450–451:266–70.
Chiang WC, Chen CY, Lee TC, Lee HL, Lin YW. Fast and simple screening for the simultaneous analysis of seven metabolites derived from five volatile organic compounds in human urine using on-line solid-phase extraction coupled with liquid chromatography-tandem mass spectrometry. Talanta. 2015;132:469–78.
Zhou X, Ye X, Calafat AM. Automated on-line column-switching HPLC–MS/MS method for the quantification of triclocarban and its oxidative metabolites in human urine and serum. J Chromatogr B. 2012;881–882:27–33.
Lee HL, Wang C, Lin S, Hsieh DPH. Liquid chromatography/tandem mass spectrometric method for the simultaneous determination of tobacco-specific nitrosamine NNK and its five metabolites. Talanta. 2007;73:76–80.
Hecht SS. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol. 1998;11:559–603.
Rivenson A, Hoffmann D, Prokopczyk B, Amin S, Hecht SS. Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and areca-derived N-nitrosamines. Cancer Res. 1988;48:6912–7.
Upadhyaya P, Carmella SG, Guengerich FP, Hecht SS. Formation and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers in vitro in mouse, rat and human tissues. Carcinogenesis. 2000;21:1233–8.
Carmella SG, Han S, Fristad A, Yang Y, Hecht SS. Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine. Cancer Epidemiol Biomarkers Prev. 2003;12:1257–61.
Jing M, Wang Y, Upadhyaya P, Jain V, Yuan JM, Hatsukami DK, et al. Liquid chromatography–electrospray ionization–tandem mass spectrometry quantitation of urinary [pyridine-d4]4-hydroxy-4-(3-pyridyl)butanoic acid, a biomarker of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolic activation in smokers. Chem Res Toxicol. 2014;27:1547–55.
Chung CJ, Pu YS, Shiue HS, Lee HL, Lin P, Yang HY, et al. 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism-related enzymes gene polymorphisms, NNK metabolites levels and urothelial carcinoma. Toxicol Lett. 2013;216:16–22.
Yang JY, Ahn HK, Lee SW, Han YJ, Oh YJ, Velázquez-Armenta EY, et al. Simple high-throughput analytical method using ultra-performance liquid chromatography coupled with tandem mass spectrometry to quantify total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine. Clin Chem Lab Med. 2015;53:1249–57.
Carmella SG, Akerkar SA, Richie JP, Hecht SS. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers’ urine. Cancer Epidemiol Biomark Prev. 1995;4:635–42.
Wall MA, Johnson J, Jacob P, Benowitz NL. Cotinine in the serum, saliva, and urine of nonsmokers, passive smokers, and active smokers. Am J Public Health. 1988;78:699–701.
Behera D, Uppal R, Majumdar S. Urinary levels of nicotine & cotinine in tobacco users. Indian J Med Res. 2003;118:129–33.
Zielinska-Danch W, Wardas W, Sobczak A, Szoltysek-Boldys I. Estimation of urinary cotinine cut-off points distinguishing non-smokers, passive and active smokers. Biomarkers. 2007;12:484–96.
Ravanat JL, Duretz B, Guiller A, Douki T, Cadet J. Isotope dilution high-performance liquid chromatography-electrospray tandem mass spectrometry assay for the measurement of 8-oxo-7,8-dihydro-2′-deoxyguanosine in biological samples. J Chromatogr B. 1998;715:349–56.
Valavanidis A, Vlachogianni T, Fiotakis K. Tobacco smoke: involvement of reactive oxygen species and stable free radicals in mechanisms of oxidative damage, carcinogenesis and synergistic effects with other respirable particles. Int J Environ Res Public Health. 2009;6:445–62.
O’Neill IK, Fishbein L. An IARC manual series aimed at assisting cancer epidemiology and prevention. “Environmental carcinogens: selected methods of analysis”. Int J Environ Anal Chem. 1986;26:229–40.
Goniewicz ML, Eisner MD, Lazcano-Ponce E, Zielinska-Danch W, Koszowski B, Sobczak A, et al. Comparison of urine cotinine and the tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and their ratio to discriminate active from passive smoking. Nicotine Tob Res. 2011;13:202–8.
Zhang P, Lian K, Wu X, Yao M, Lu X, Kang W, et al. Evaluation of the oxidative deoxyribonucleic acid damage biomarker 8-hydroxy-2′-deoxyguanosine in the urine of leukemic children by micellar electrokinetic capillary chromatography. J Chromatogr A. 2014;1336:112–9.
Chiang HC, Huang YK, Chen PF, Chang CC, Wang CJ, Lin P, et al. 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone is correlated with 8-hydroxy-2′-deoxyguanosine in humans after exposure to environmental tobacco smoke. Sci Total Environ. 2012;414:134–9.
Acknowledgments
This study was supported by grants number MOST104-2113-M-030-004 from the Ministry of Science and Technology, Taiwan.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Informed consents
The informed consents were signed by all individual participants before they participated this study.
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(PDF 51 kb)
Rights and permissions
About this article
Cite this article
Chen, CY., Jhou, YT., Lee, HL. et al. Simultaneous, rapid, and sensitive quantification of 8-hydroxy-2′-deoxyguanosine and cotinine in human urine by on-line solid-phase extraction LC-MS/MS: correlation with tobacco exposure biomarkers NNAL. Anal Bioanal Chem 408, 6295–6306 (2016). https://doi.org/10.1007/s00216-016-9741-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-016-9741-3